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ABSTRACT In Saccharomyces cerevisiae, the genes encod-
ing at least 10 enzymes involved in DNA replication are
periodically expressed in the late GI and S phases of the cell
cycle. All of these genes have one copy or more of the sequence
ACGCGT, which conforms to the recognition site for the Mlu
I restriction endonuclease. For the CDC21, CDC9, and POLl
genes, the Mlu I site has been shown to be absolutely required
for periodic transcription. Using nuclear extracts fractionated
by conventional and oligonucleotide affinity chromatography,
we have purified a 17-kDa protein that recognizes the Ml4 I
motif. Synthetic oligonucleotides containing mutated Mlu I
sites do not bind the protein. In contrast, synthetic oligonu-
cleotides derived from the CDC2, CDC6, and CDC21 genes,
which are expressed with the same timing as POLI, bind
purified protein efficiently.
In Saccharomyces cerevisiae, cells make the decision to
enter a round ofDNA synthesis and duplication at a point in
G1 called Start (1). Although we know little about the events
that occur between Start and S phase, one landmark is an
induction of the RNAs encoding at least 10 genes involved in
DNA replication. Thus, genes encoding proteins at the rep-
lication fork such as POLI (DNA polymerase a) (2, 3), PRIJ
and PRI2 (subunits of primase) (4, 5), CDC2 (DNA polymer-
ase 6), and POL30 (proliferating cell nuclear antigen) (6) are
all maximally transcribed at the G1/S boundary. In addition,
the genes encoding some of the enzymes involved in the
production ofdNTPs are also expressed periodically with the
same peak of timing. Examples include CDC8, encoding
thymidylate kinase (7), CDC21, encoding thymidylate syn-
thase (8), and ribonucleotide reductase (9, 10). Another
example is CDC9, encoding DNA ligase, required for com-
pletion of DNA synthesis (11, 12). The expression of these
genes depends, either directly or indirectly, on Start (7, 13),
and studies that elucidate the molecular mechanism of this
Start dependence should complement the use of CDC mu-
tants in defining events set in motion by Start.
The sequence 5'-ACGCGT-3', the recognition sequence
for Mlu I restriction endonuclease, is the only sequence
conserved among the promoters of the replication genes (14)
and is necessary for periodic transcription for the CDC21 (15,
16), CDC9 (17), and PJLJ genes (18). A region of 54
nucleotides in the POLl promoter, having two Mlu I sites
spaced 29 base pairs (bp) apart, contains all the information
necessary for transcriptional expression and periodic activa-
tion. Oligonucleotides containing either one of the Mlu I sites
can confer UAS activity on a heterologous gene. Since the
flanking sequences differ at each site, the Mlu I sequence
alone appears to be sufficient for cell cycle regulation. This
conclusion is supported by the demonstration that an oligo-
nucleotide carrying a single Mlu I site flanked by sequences
that are a mixture of the sequences adjacent to both sites in
the natural promoter confers periodicity (18). The Mlu I site
is necessary for the periodic expression of the CDC21 and
CDC9 promoters as well (16, 17), suggesting coordinate
regulation of the entire set of periodic replication genes
through Mlu I sites. We have designated the UAS that is
involved the Mlu I cell cycle box (MCB).
The MCB is a potential target for a trans-acting factor that
responds either directly or indirectly to Start. Identification
of such a factor in an organism such as yeast should facilitate
a combined biochemical and genetic analysis of this distinc-
tive type of regulated gene expression. In this study, we
report the purification of such a specific binding factor. We
have designated the protein MCBF for MCB binding factor.
The purified protein binds in a Mlu I-specific fashion to the
POLI promoter as well as to oligonucleotides derived from
three additional periodic genes containing Mlu I sites in their
promoters.
MATERIALS AND METHODS
Preparation of Labeled Probes for DNA Binding Assays.
Complementary strands of the oligonucleotides listed in
Table 1 were annealed and labeled with T4 polynucleotide
kinase and [y-32P]ATP. The 60-bp oligonucleotide (PU1) has
previously been shown to function as a UAS that confers
periodicity on the heterologous CYCI promoter (18). For
footprinting analysis, PU1 was cloned into the BamHI site of
the Bluescript vector pBS (Stratagene). Cleavage at the Not
I site in the pBS polylinker, followed by phosphatase end-
labeling with T4 polynucleotide kinase, and digestion with
Xho I generated the 130-bp noncoding strand. The coding
strand was prepared by cutting with Xho I, labeling with T4
kinase, and then cleaving with Sac I to yield a 150-bp
fragment.
Preparation of Oligonucleotide Affinity Column. The 60-bp
PU1 oligonucleotide was phosphorylated with T4 kinase,
annealed, ligated, and coupled to Sepharose CL2B essen-
tially according to the method of Kadonaga and Tjian (19). A
column consisting of 1.5 mg of PU1 oligonucleotide coupled
to 10 ml (settled volume) of Sepharose was used.
DNA Binding Reactions. DNA binding activity was moni-
tored by altered electrophoretic mobility ofthe protein-DNA
complex compared to free DNA (20, 21) as described (22).
For DNase I footprinting, samples were digested with
DNase I at room temperature for 1 min using different
dilutions of a stock solution of enzyme (5 mg/ml).
Preparation of Nuclear Extract: S. cerevisiae. PEP4D
(MA Ta/a,hisl/ +,trpl/ + ,pep4-3/pep4-3,prcl-126/prcl-
126,prbl-1122/prbl-1122,canl/cant) was grown in a 350-liter
Abbreviations: UAS, upstream activation sequence; MCB, MIu I cell
cycle box; MCBF, MCB binding factor.
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Table 1. Oligonucleotides used
Oligo- Length,
nucleotide bp Sequence
PUl 60 GATCACGCGACTTTTACTTATAGGCTAACAAAAAAATTTTAAjQCGTTGAATAGAG
TGCGCTGCGCAAAATGAATATCCGATTGTTTTTTTAAAATTGCGCAAACTTATCTCCTAG
PU4 48 GATCTCGCGTTTACTTATAGGCTAACAAAAAAATTTTATTGAATAGAG
AGCGCAAATGAATATCCGATTGTTTTTTTAAAATAACTTATCTCAGCT
C21 60 AATTTTGGTGAICTAAATAGAAAAAATGAAAAAGACCTTAATTGACGTTTCCTGA
AACCACTGCGCAATTTATCTTTTTTACTTTTTCTGGAATTAACTGCGCAAAGGACTTTAA
C6 60 GATCCCAAAGAAGAAAGCGACAGGCCTCACGCGTCGGAGTTTCCAGATCAGG
GGTTTCTTCTTTCGCTGCGCTCGGGAGTGCGCAGCCTCAAAGGTCTAGTCCCTAG
C2 60 GATCCCTTAACGTAATAGGCAATTTTTCGTATTA.CGC.AACTTTTTATTCTATAAAATG
GGAATTGCATTATCCGTTAAAAAGCATAATGCGCATTGAAAAATAAGATATTTTACCTAG
PU2 25 GATCATAAGTAAAAC9 M CGCGTG
TATTCATTTTGCGCAGCGCACCTAG
PU3 25 GATCTCTATTCAAACg.GTTAAAAT
AGATAAGTTTGCGCAATTTTACTAG
PU8 25 GATCTCTATTCAAAUtCGITAAAAT
AGATAAGTTTGaGCAATTTTACTAG
PU9 25 GATCTCTATTCAAAM..aITAAAAT
AGATAAGTTTGCGtAATTTTACTAG
PUMO 25 GATCTCGCGA~tLcTTTGAATAGAG
AGCGCTGaGgAAACTTATCTCCTAG
PUll 25 GATCATAAGTAAAAtCQItGCGTG
TATTCATTTTGaGgAaCTCACCTAG
PU12 25 GATCTCTATTCAA LQQ.TTgAAAT
AGATAAG'TTGaGgAACTTTACTAG
ABF1 33 GAATTCATTTCTTAGCATTTTTGACGAAATTTG
TAAAGAATCGTAAAAACTGCTTTAAACCTTAAG
Bluescript 24 CTAGTGGATCCCCCGGGCTGCAGG
polylinker ACCTAGGGGGCCCGACGTCCTTAA
The top strand is listed 5' to 3'. Base-pair changes in the mutant oligonucleotides are shown in lowercase letters.
fermenter to midlogarithmic phase in medium containing 1%
yeast extract, 2% peptone, and 2% cerelose at 30°C. Cells
were harvested in a Sharples centrifuge and the cell pellets
were frozen in liquid nitrogen and stored at -70°C. Nuclear
extract was prepared as described by Yoon and Campbell
(23). Nuclei were resuspended in 50 mM Tris HCl, pH 7.5/5
mM MgCl2/3 mM dithiothreitol containing a protease inhib-
itor mixture of 1 mM phenylmethylsulfonyl fluoride, 1 mM
benzamidine, and leupeptin, pepstatin, and soybean trypsin
inhibitor at 10 ,ug/ml. They were lysed by addition of
ammonium sulfate to a final concentration of 0.4 M. The
lysate was centrifuged at 35,000 rpm for 20 min in a Beckman
TiOO rotor. Ammonium sulfate (0.56 g/ml) was added and the
precipitate was collected by centrifugation at 35,000 rpm for
30 min at 40C. The pellet was dissolved in a buffer containing
20 mM Hepes (pH 8), 10% (vol/vol) glycerol, 1 mM EDTA,
1 mM phenylmethylsulfonyl fluoride, 1 mM benzamidine
(buffer A), and 100 mM KCI and dialyzed against the same
buffer.
RESULTS
Identification of a Specific MCB Binding Activity. Standard
DNA binding studies were conducted with oligonucleotide
probes derived from the POLI promoter (Table 1). PU1
contains 54 bp from the POLI promoter with two Mlu I sites
spaced 29 bp apart and is sufficient for cell cycle-regulated
transcription of a heterologous promoter (18). At least five
protein-DNA complexes were observed when nuclear ex-
tract was incubated with PU1 as a probe. Although some of
them were blocked by competition with PU1 and not by the
heat shock element, they were also blocked by competition
with PU4. PU4 does not confer periodicity to a heterologous
promoter in vivo (18). To enrich for Mlu I-specific proteins,
nuclear extracts prepared on an analytical scale were frac-
tionated on a PU1 oligonucleotide affinity column as de-
scribed below. Several proteins that recognized the cloned
PU1 probe were observed eluting at different salt concentra-
tions. A protein eluting at 0.7 M salt that gave rise to a
complex with relatively high mobility was judged to be
specific for the MCB, as demonstrated by the data in Fig. 1.
Lane 1 shows complex formation in the presence of 1 ,g of
poly[d(IC)] but in the absence of added test competitor.
Formation of this complex was not blocked by competition
with nonspecific DNA, such as the recognition site for ARS
binding factor 1 (22) or an oligonucleotide carrying sequences
from the Bluescript polylinker. Similarly, PU4, which con-
tains no Mlu I sites but is otherwise identical to PU1, does not
compete. Binding was blocked by competition with PU1
itself. A single Mlu I site is sufficient to confer periodic
transcription in vivo, and, consistent with this, a single Mlu
I site is sufficient for formation of this complex, as evidenced
by complete competition by the PU2 and PU3 oligonucleo-
tides. These 25-bp oligonucleotides contain the proximal and
distal Mlu I sites, respectively, which have different flanking
DNA sequences. [The Mlu I site nearest the ATG translation
start site (-173 to -168) is referred to as the proximal site,
and the Mlu I site at -208 to -203 is referred to as the distal
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FIG. 1. Identification ofa specific MCB binding activity. Nuclear
extract was fractionated on a PU1 oligonucleotide affinity column
and assayed with labeled PUI cloned into Bluescript. Binding
activity eluting at 0.7 M salt was assayed in the presence of 1 ;Lg of
poly(dI-dC) (lane 1) or 850 ng of poly(dl-dC) and 150 ng ofcompetitor
DNA (30-fold excess over probe DNA; all other lanes). Competitors
used are listed above the lanes and their sequences are presented in
Table 1. The protein-DNA complex judged to be specific is marked
by an arrow.
site in this work.] Finally, an oligonucleotide derived from
PU3 but containing three point mutations (PU12) did not
compete for binding.
An oligonucleotide derived from the CDC21 promoter,
C21, contains two Mlu I motifs, which have been shown to
be necessary for periodic UAS function (15, 16). There is no
other sequence similarity between the two promoters. As
shown in lane 9, C21 also competed for binding.
Purification of MCBF. To further characterize the DNA
binding protein, which we refer to as MCBF, we used
formation of this complex as an assay to purify the protein.
The dialyzed nuclear extract, containing 3 g of protein, was
loaded onto a heparin-Sepharose column. The peak of bind-
ing activity eluted at 0.4 M KCI and contained 300 mg of
protein. The activity was loaded onto the oligonucleotide
affinity column in three samples of 100 mg each. Specific
binding activity eluted at 0.5-0.6 M salt. The peaks ofactivity
from the three different runs were pooled and contained 2.2
mg of protein. The fraction was dialyzed and loaded onto a
Mono S FPLC column. Specific binding activity eluted at 0.7
M salt. Approximately 150 ,ug of protein was recovered from
this step, representing a 10,200-fold purification from the
nuclear extract, based on protein recovery.
A dosage binding experiment was carried out with Mono S
purified fractions (Fig. 2 A and B). The Mono S fraction is
composed only of the specific DNA binding species. As the
protein concentration is increased, multimeric forms of the
complex are observed, all of which can be blocked by
competition with specific oligonucleotides (data not shown).
The multimeric forms could be a consequence of the factor
binding on the two Mlu I sites of PU1 or multimeric inter-
actions at a single Mlu I site.
Specificity ofbinding of the purified protein was confirmed
by using the mutant oligonucleotides listed in Table 1 in
competition binding experiments. The mutants to be tested
were designed based on conservation of the nucleotides at
specific positions within and surrounding the Mlu I sites in
the promoters of 10 similarly regulated genes. Although the
entire ACGCGT sequence is conserved in at least 8 replica-
tion genes (24), a few of them such as PRII and TS26 that are
periodically expressed have 5/6-bp matches (4, 25). If these
are functional, the consensus sequence is ACGNG. Oligo-
nucleotides carrying single, double, and triple point muta-
tions were synthesized. The single mutations tested were
made in theIwo internal G residues, as these are absolutely
conserved nucleotides. PU8 and PU9, containing a single G
to T transversion or a G to A transition, respectively, do not
FIG. 2. Characterization ofthe purified protein. (A) Gel mobility-
shift analysis. Increasing amounts of oligonucleotide affinity (lanes
1-3; 3, 6, and 10 Al, respectively) and Mono S purified MCBF (lanes
4-6; 3, 6, and 10 /dJ, respectively) were incubated with a fixed amount
of probe DNA. The specific complexes are marked by arrows. (B)
Competition analysis of affinity peak. Purified protein was assayed
in the presence of poly(dIldC) (1.0 ,ug) alone (lane 1) or poly(dI-dC)
(0.7 ,ug) and competitor DNA (0.3 Ag) (all other lanes). Lanes: 2,
triple mutant, PU11; 3, double mutant, PU10; 4 and 5, single mutants
PU8 and PU9, respectively; 6, wild-type competitor, PU2.
compete for binding (Fig. 2). In addition, PU11 mutant
oligonucleotide, when labeled with 32P and used as a probe,
does not form a complex (data not shown).
Footprinting Analysis. Standard DNase I footprinting re-
actions shown in Fig. 3A (noncoding strand) and B (coding
strand), demonstrate that binding of MCBF is at the Mlu I
sites. Both the proximal as well as the distal Mlu I sites were
well resolved in the noncoding strand (Fig. 3A), and protec-
tion was observed within each Mlu I site extending to a few
bases beyond the site. Similarly, the distal Mlu I site is clearly
protected in the coding strand (Fig. 3B). The proximal Mlu I
site is not very well resolved in the coding strand (Fig. 3B),
but an effect on the site is still apparent. Additional evidence
that protection from DNase I digestion occurs at specific sites
is demonstrated by the competition experiment in Fig. 3C.
Using the well resolved noncoding strand, protection is
observed in the absence ofadded oligonucleotide competitor.
This protection is abolished by inclusion of cold PUl, con-
taining both Mlu I sites, as well as by PU2, containing the
single proximal Mlu I site. In contrast, the protection is not
blocked by competition with mutant Mlu I oligonucleotides
PU11 or PU12. Thus, footprinting confirms the Mlu I spec-
ificity of this protein.
SDS/Polyacrylamide Gel Analysis of MCBF. The purity of
MCBF was assessed by SDS/polyacrylamide gel analysis
(Fig. 4). The Mono S fraction is enriched in a species of -17
kDa. A lower abundance 15-kDa species is also seen, which
may or may not represent degradation of the 17-kDa protein.
For Southwestern analysis (26), the Mono S fraction was run
on a separate SDS gel, and the proteins were transferred to
nitrocellulose. After protein renaturation, the filter was in-
cubated with 32P-labeled probe. A major DNA binding spe-
cies of 17 kDa was detected, together with a faint lower
band of 15 kDa. Thus, the 17-kDa species is most likely
MCBF.
Binding of MCBF to Promoters of Other Periodic Genes
Containing Mlu I Motifs. A major question raised by the
occurrence of the Mlu I site in several promoters regulated
with similar timing is the extent to which coordinate control
occurs. We have investigated the CDC21, CDC2 (DNA
polymerase 6), and CDC6 (gene product required for DNA
synthesis initiation) genes. Sixty-base-pair oligonucleotides
from the regions containing the Mlu I sites were synthesized.
The C21 oligonucleotide derived from CDC21 has two Mlu I
---
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sites spaced 31 bp apart, almost the same spacing as POLL.
There is no sequence similarity in the region between the two
promoters except for an A+T-rich base composition. The C6
oligonucleotide derived from CDC6 contains one exact Mlu
I site and a 5/6 match spaced 6 bp apart (27). The C2
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FIG. 4. SDS/polyacrylamide gel analysis of MCBF. (A) Oligo-
nucleotide affinity (lane 1) and Mono S (lane 2) purified MCBF
preparations were resolved on a SDS/15% polyacrylamide gel and
the proteins present were visualized by silver staining. (B) Mono S
FPLC purified MCBF was resolved on a SDS/13% polyacrylamide
gel, transferred to nitrocellulose after renaturation, and probed with
[32P]DNA.
-o _ FIG. 3. Specificity of DNase I protec-
j tion by MCBF. (A) Noncoding strand. The
extent of protection observed using both
affinity and Mono S purified protein is
ma__j delineated by solid boxes. Lanes -, no
protein added; lanes +, protein added.
Three times more protein as well as
_ poly(dI-dC) was used for the affinity-
purified MCBF reactions. The sequence
protected is shown on the left and tick
marks indicate the two invariant G resi-
dues in the consensus ACGCGT. G and
G/A represent Maxam-Gilbert sequenc-ing ladders. (B) Coding strand probe. (C)
_W _W 46 Competition binding. Footprinting reac-tions used the noncoding strand and affin-
ity-purified MCBF. Competitors tested
were wild-type PU1 or PU2 and mutants
PU11 or PU12 as marked.
oligonucleotide derived from the CDC2 promoter contains a
single Mlu I site.
C21, C2, C6, as well as PU1 were labeled and used as
binding probes. The C21 oligonucleotide formed a complex
with MCBF of similar mobility to that with PU1 (Fig. 5 A and
B). Complex formation was efficiently blocked by competi-
tion with cold C21 as well as PU1 and PU2. In contrast, the
mutant PU11 did not compete. Since the sequences between
the two Mlu I sites are A+T-rich, while the Mlu I site has the
CGCG motif, poly(dT) and poly(dC-dG) were also tested as
competitors. As shown in lanes 7, poly(dT) did not compete
and actually enhanced complex formation. Poly(dC*dG) does
compete, although its efficiency as a competitor on a molar
basis is less than that of PUL. Almost identical results were
obtained with C2 oligonucleotide (Fig. 5C) and with C6
oligonucleotide (Fig. SD). Thus, MCBF has the DNA binding
properties expected of a protein involved in coordinate
regulation of these genes in the cell cycle.
DISCUSSION
In this report, we describe the purification of MCBF, a
protein that binds to the MCB element that we have previ-
ously shown is part of a UAS that is necessary and sufficient
for periodic expression of the POLI gene in the yeast cell
cycle (18). The protein has an apparent molecular mass of 17
kDa. Southwestern analysis of the fraction shows that Mlu I
binding activity resides in the 17-kDa polypeptide (Fig. 4).
The report of a highly purified yeast protein that recognizes
a DNA sequence involved in cell cycle regulation is of
interest because it allows a reverse genetic analysis of how
this protein senses position in the cell cycle.
Specificity of binding was established by footprinting and
competition analysis and by the demonstration that MCBF
binds to three other Mlu I-containing promoters. The critical
determinant for binding seems to be the Mlu I site per se and
not the flanking sequences since (i) footprinting reactions
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FIG. 5. Binding of MCBF to different promoters containing Mlu I sites. Affinity-purified MCBF was tested for binding with POLI-derived
PUl oligonucleotide (A), CDC21-derived C21 oligonucleotide probe (B), CDC2-derived C2 oligonucleotide probe (C), and CDC6-derived C6
oligonucleotide probe (D) (arrows). Total DNA concentration was kept constant at 1.2 gg for all binding reactions using poly(dI-dC) alone (lane
1) or 800 ng ofpoly(dIldC) and 400 ng ofcompetitors (80x over probe DNA; all other lanes). Competitors tested are indicated and their sequences
are given in Table 1.
showed protection of both the proximal and distal POLI Mlu
I sites, which have dissimilar flanking sequences (Fig. 3), and
(ii) sequences shared by the CDC21, CDC2, CDC6, and
POLl promoters are limited exclusively to the Mlu I site. The
sequences adjacent to Mlu I therefore seem unnecessary for
recognition. Since the Mlu I site has been shown to be
necessary and sufficient for periodic expression in vivo,
MCBF is a good candidate for the transcription factor that
mediates this timing.
Footprinting data and competitive binding allow some new
conclusions about the bases important for recognition. Al-
though the entire ACGCGT sequence is conserved in at least
eight periodically expressed replication genes (24), PRII and
TS26 have only 5/6 matches, while CDC6 has one exact site
and a 5/6 match. Assuming these 5/6 matches contribute to
periodic expression of these genes, the functional consensus
sequence ACGNG can be derived. Changing the 5' G to a T
or the 3' G to an A abolishes the competition observed with
wild-type sequence in vitro. Changing both G residues is also
deleterious (Fig. 2B). Thus, the two invariant G residues
seem to be very important for recognition. It is interesting
that McIntosh et al. (16) have shown by site-directed muta-
genesis that mutations in either G at the distal Mlu I site in the
CDC21 promoter almost completely abolish transcription
from that promoter in vivo.
The ready availability of large quantities of pure MCBF
will allow us to use a concurrent genetic and biochemical
investigation of the mechanism by which MCBF confers
periodicity to POLL. Recent studies that have demonstrated
Mlu I-specific protein-DNA complex formation in yeast
extracts suggest that the Mlu I binding activity may fluctuate
in the cell cycle with approximately the same periodicity as
the mRNA of CDC9 (17). Thus, MCBF may be periodically
either synthesized or phosphorylated in G1 by CDC28 kinase,
the activity of which is essential for completion of Start (28).
Although the HO gene is periodically transcribed with
apparently the same peak of timing as the DNA synthesis
genes (29), the periodicity is due to a cis-acting element
(RNYCACGAAAA) (R, purine; Y, pyrimidine) quite distinct
from the Mlu I motif (30). Two genes, SWI4 and SWI6, have
been shown to be required for activation ofHO transcription
in G1 (31). The pleiotropic phenotypes associated with swi4
and swi6 mutants suggest that they may participate in con-
trolling essential processes in the cell besides regulating HO
gene expression. The identification ofMCBF allows us to test
its presence and activation in swi4 and swi6 mutants.
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